You XF - Search Results

1

Synthesis and Bioactivity Investigation of the Individual Components of Cyclic Lipopeptide Antibiotics.

Cui AL, Hu XX, Gao Y, Jin J, Yi H, Wang XK, Nie TY, Chen Y, He QY, Guo HF, Jiang JD, You XF, Li ZR. Cui AL, et al. Among authors: you xf. J Med Chem. 2018 Mar 8;61(5):1845-1857. doi: 10.1021/acs.jmedchem.7b01367. Epub 2018 Feb 15. J Med Chem. 2018. PMID: 29412662

2

Antiviral therapeutic efficacy of foscarnet in hepatitis B virus infection.

Han YX, Xue R, Zhao W, Zhou ZX, Li JN, Chen HS, Chen XH, Wang YL, Li YH, Wu YW, You XF, Zhao LX, Jiang JD. Han YX, et al. Among authors: you xf. Antiviral Res. 2005 Dec;68(3):147-53. doi: 10.1016/j.antiviral.2005.09.002. Epub 2005 Oct 25. Antiviral Res. 2005. PMID: 16280177 Clinical Trial.

3

[Advances in molecular biology of extended-spectrum beta-lactamase].

Xiang Q, You XF, Jiang JD. Xiang Q, et al. Among authors: you xf. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2006 Apr;28(2):298-303. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2006. PMID: 16733924 Review. Chinese.

4

In vitro activity of recombinant lysostaphin against Staphylococcus aureus isolates from hospitals in Beijing, China.

Yang XY, Li CR, Lou RH, Wang YM, Zhang WX, Chen HZ, Huang QS, Han YX, Jiang JD, You XF. Yang XY, et al. Among authors: you xf. J Med Microbiol. 2007 Jan;56(Pt 1):71-76. doi: 10.1099/jmm.0.46788-0. J Med Microbiol. 2007. PMID: 17172520

5

Synthesis and anti-influenza activities of carboxyl alkoxyalkyl esters of 4-guanidino-Neu5Ac2en (zanamivir).

Liu ZY, Wang B, Zhao LX, Li YH, Shao HY, Yi H, You XF, Li ZR. Liu ZY, et al. Among authors: you xf. Bioorg Med Chem Lett. 2007 Sep 1;17(17):4851-4. doi: 10.1016/j.bmcl.2007.06.049. Epub 2007 Jun 20. Bioorg Med Chem Lett. 2007. PMID: 17611105

6

Combination of simvastatin with berberine improves the lipid-lowering efficacy.

Kong WJ, Wei J, Zuo ZY, Wang YM, Song DQ, You XF, Zhao LX, Pan HN, Jiang JD. Kong WJ, et al. Among authors: you xf. Metabolism. 2008 Aug;57(8):1029-37. doi: 10.1016/j.metabol.2008.01.037. Metabolism. 2008. PMID: 18640378 Clinical Trial.

7

In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.

Li CR, Yang XY, Lou RH, Zhang WX, Wang YM, Yuan M, Li Y, Chen HZ, Hong B, Sun CH, Zhao LX, Li ZR, Jiang JD, You XF. Li CR, et al. Among authors: you xf. Antimicrob Agents Chemother. 2008 Nov;52(11):3875-82. doi: 10.1128/AAC.01400-07. Epub 2008 Aug 18. Antimicrob Agents Chemother. 2008. PMID: 18710917 Free PMC article.

8

N-(2,6-dimethoxypyridine-3-yl)-9-methylcarbazole-3-sulfonamide as a novel tubulin ligand against human cancer.

Wang YM, Hu LX, Liu ZM, You XF, Zhang SH, Qu JR, Li ZR, Li Y, Kong WJ, He HW, Shao RG, Zhang LR, Peng ZG, Boykin DW, Jiang JD. Wang YM, et al. Among authors: you xf. Clin Cancer Res. 2008 Oct 1;14(19):6218-27. doi: 10.1158/1078-0432.CCR-08-0550. Clin Cancer Res. 2008. PMID: 18829501

9

Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression.

Kong WJ, Zhang H, Song DQ, Xue R, Zhao W, Wei J, Wang YM, Shan N, Zhou ZX, Yang P, You XF, Li ZR, Si SY, Zhao LX, Pan HN, Jiang JD. Kong WJ, et al. Among authors: you xf. Metabolism. 2009 Jan;58(1):109-19. doi: 10.1016/j.metabol.2008.08.013. Metabolism. 2009. PMID: 19059538

10

In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.

You XF, Li CR, Yang XY, Yuan M, Zhang WX, Lou RH, Wang YM, Li GQ, Chen HZ, Song DQ, Sun CH, Cen S, Yu LY, Zhao LX, Jiang JD. You XF, et al. Antimicrob Agents Chemother. 2009 Oct;53(10):4525-8. doi: 10.1128/AAC.00223-09. Epub 2009 Jul 27. Antimicrob Agents Chemother. 2009. PMID: 19635958 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

172 results

Search Page